PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Francesca Maria Rossi Davide Rossi Ivo Kwee Matthias P Wymann Petra Hillmann Alexander M Sele Luciano Cascione Alberto Arribas-Romano Francesco Bertoni Chiara Tarantelli Laura Carrassa Elena Bernasconi Georg Stüssi Anastasios Stathis Vladimir Cmiljanovic Denise Rageot Andreas Wicki Doriano Fabbro Filippo Spriano Florent Beaufils Valter Gattei Antonella Zucchetto Emanuele Zucca |
| Publication date | October 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |